CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action 
CCHR Says New OIG Report Raises Concerns about Drugging Elderly with Antipsychotics 
Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP) 
Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth 
CCHR Rejects Global Psychiatric Push to Electroshock Children Acuvance Earns 2026 Great Place to Work® Certification 
Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability 
Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking 
Top Periodontist in region joins PearlFection Dentistry